
Cytokinetics Inc
NASDAQ:CYTK

Intrinsic Value
The intrinsic value of one
CYTK
stock under the Base Case scenario is
32.56
USD.
Compared to the current market price of 31.06 USD,
Cytokinetics Inc
is
Undervalued by 5%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Cytokinetics Inc
Fundamental Analysis


Revenue & Expenses Breakdown
Cytokinetics Inc
Balance Sheet Decomposition
Cytokinetics Inc
Current Assets | 956.1m |
Cash & Short-Term Investments | 938.2m |
Receivables | 2m |
Other Current Assets | 15.8m |
Non-Current Assets | 308m |
Long-Term Investments | 150.7m |
PP&E | 144.6m |
Other Non-Current Assets | 12.7m |
Free Cash Flow Analysis
Cytokinetics Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Cytokinetics Inc
Revenue
|
19.2m
USD
|
Operating Expenses
|
-584.9m
USD
|
Operating Income
|
-565.6m
USD
|
Other Expenses
|
-49.6m
USD
|
Net Income
|
-615.3m
USD
|
CYTK Profitability Score
Profitability Due Diligence
Cytokinetics Inc's profitability score is 64/100. The higher the profitability score, the more profitable the company is.

Score
Cytokinetics Inc's profitability score is 64/100. The higher the profitability score, the more profitable the company is.
CYTK Solvency Score
Solvency Due Diligence
Cytokinetics Inc's solvency score is 43/100. The higher the solvency score, the more solvent the company is.

Score
Cytokinetics Inc's solvency score is 43/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
CYTK Price Targets Summary
Cytokinetics Inc
According to Wall Street analysts, the average 1-year price target for
CYTK
is 78.54 USD
with a low forecast of 41.41 USD and a high forecast of 126 USD.
Dividends
Current shareholder yield for CYTK is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
CYTK
stock under the Base Case scenario is
32.56
USD.
Compared to the current market price of 31.06 USD,
Cytokinetics Inc
is
Undervalued by 5%.